Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker’s experimental mRNA bird-flu vaccine.
Source: https://www.marketwatch.com/story/moder ... topstories
Moderna’s stock climbs on report that bird-flu vaccine funding is near
